Skip to content
February 26, 2026
  • Over 90% of Cough Syrup Manufacturers Audited-DCGI Rajeev Singh
  • Supreme Court Seeks Details on Cost and Availability of NAT Testing in Govt Hospitals
  • Heart Attack Risk May Begin at Lower Plaque Levels in Women: Study
  • President Droupadi Murmu Pitches for Affordable and Inclusive Healthcare
tishha_logo

Tishha News

  • Home
  • News
  • Economics
  • Technology Innovations
  • Global Healthcare
  • Expert Talks
  • Web Stories
  • Home
  • Sarvesham Manglam Foundation

Sarvesham Manglam Foundation

image 42
  • News

Supreme Court Seeks Details on Cost and Availability of NAT Testing in Govt Hospitals

tishha_newsFebruary 26, 2026February 26, 202603 mins

The Supreme Court has asked for detailed information on the cost and availability of Nucleic Acid Amplification Testing (NAT) in…

Read More

Most Viewed

News
Over 90% of Cough Syrup Manufacturers Audited-DCGI Rajeev Singh
India’s drug regulator has said that more than 90% of…
News
Supreme Court Seeks Details on Cost and Availability of NAT Testing in Govt Hospitals
The Supreme Court has asked for detailed information on the…

Random

1

Over 90% of Cough Syrup Manufacturers Audited-DCGI Rajeev Singh

  • News
2

Supreme Court Seeks Details on Cost and Availability of NAT Testing in Govt Hospitals

  • News
3

Heart Attack Risk May Begin at Lower Plaque Levels in Women: Study

  • News
4

President Droupadi Murmu Pitches for Affordable and Inclusive Healthcare

  • News
5

JP Nadda Launches AI-Driven E-ICU Command Centre at Yashoda Medicity

  • News
6

Centre to Launch Free Nationwide HPV Vaccination Drive for Adolescent Girls

  • News
7

Aster DM Healthcare to Invest ₹2,300 Crore in India Expansion, Plans 2,368 New Beds

  • News
8

NMC Proposes Mandatory Corpus Fund for All Medical Colleges

  • News
tishha_logo
TISHHA News Developed By BlazeThemes.